tiprankstipranks
Trending News
More News >
SinoMab Bioscience Ltd. (HK:3681)
:3681
Hong Kong Market

Compare SinoMab Bioscience Ltd. (3681) vs. Competitors

Compare
1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
SinoMab Bioscience Ltd.
HK$1.39
HK$1.87B
-9.46
34.65%
RemeGen Co. Ltd. Class H
HK$84.20
HK$58.04B
-44.61
534.04%
4 Buy
2 Hold
0 Sell
Moderate Buy
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$21.38
HK$36.44B
-20.84
94.36%
0 Buy
1 Hold
0 Sell
Hold
Lepu Biopharma Co. Ltd. Class H
HK$4.98
HK$8.66B
-41.39
70.70%
Jiangsu Recbio Technology Co., Ltd. Class H
HK$4.18
HK$2.40B
-3.40
-39.57%
Shanghai Henlius Biotech, Inc. Class H
HK$58.60
HK$31.14B
34.99
241.89%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:3681
SinoMab Bioscience Ltd.
1.36
0.35
34.65%
HK:9995
RemeGen Co. Ltd. Class H
84.20
70.60
519.12%
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
21.38
10.78
101.70%
HK:2157
Lepu Biopharma Co. Ltd. Class H
4.66
1.77
61.25%
HK:2179
Jiangsu Recbio Technology Co., Ltd. Class H
5.01
-3.34
-40.00%
HK:2696
Shanghai Henlius Biotech, Inc. Class H
57.30
40.32
237.46%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts